Ocugen Files 8-K: Rights, Bylaws, and Financials Updated
Ticker: OCGN · Form: 8-K · Filed: May 10, 2024 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | 8-K |
| Filed Date | May 10, 2024 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financials
Related Tickers: OCGN
TL;DR
Ocugen filed an 8-K updating rights, bylaws, and financials. Details TBD.
AI Summary
Ocugen, Inc. filed an 8-K on May 10, 2024, reporting material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws. The filing also includes financial statements and exhibits, but specific details regarding the nature of these modifications or amendments are not provided in the provided text.
Why It Matters
This filing indicates potential changes to Ocugen's corporate structure or shareholder rights, which could impact the company's operations and investor relations.
Risk Assessment
Risk Level: medium — Filings related to modifications of security holder rights and corporate bylaws can introduce uncertainty and potential changes that may affect the company's stock performance.
Key Players & Entities
- Ocugen, Inc. (company) — Registrant
- May 10, 2024 (date) — Date of earliest event reported
- 11 Great Valley Parkway (address) — Business and Mail Address
- Malvern, Pennsylvania (location) — City and State of Business Address
- 19355 (zip_code) — Zip Code of Business Address
- 484-328-4701 (phone_number) — Business Phone Number
FAQ
What specific material modifications were made to the rights of security holders?
The provided text of the 8-K filing does not specify the details of the material modifications to the rights of security holders.
What amendments were made to Ocugen's articles of incorporation or bylaws?
The filing indicates amendments were made, but the specific nature of these amendments to the articles of incorporation or bylaws is not detailed in the provided text.
What is the significance of filing financial statements and exhibits in this 8-K?
The inclusion of financial statements and exhibits suggests that these documents are relevant to the reported events, such as modifications to security holder rights or bylaw changes.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 10, 2024.
What is Ocugen, Inc.'s state of incorporation and IRS Employer Identification Number?
Ocugen, Inc. is incorporated in Delaware and its IRS Employer Identification Number is 04-3522315.
Filing Stats: 1,799 words · 7 min read · ~6 pages · Grade level 14.4 · Accepted 2024-05-10 16:14:11
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share OCGN The Nasdaq
Filing Documents
- tm2413925d1_8k.htm (8-K) — 37KB
- tm2413925d1_ex3-1.htm (EX-3.1) — 29KB
- 0001104659-24-059907.txt ( ) — 245KB
- ocgn-20240510.xsd (EX-101.SCH) — 3KB
- ocgn-20240510_lab.xml (EX-101.LAB) — 33KB
- ocgn-20240510_pre.xml (EX-101.PRE) — 22KB
- tm2413925d1_8k_htm.xml (XML) — 4KB
03. Material
Item 3.03. Material Modification to Rights of Security Holders. The disclosure set forth in Item 5.03 below is hereby incorporated herein by reference.
03. Amendments
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Series C Preferred Stock The board of directors (the " Board ") of Ocugen, Inc. (the " Company ") declared a dividend of one one-thousandth (1/1,000th) of a share of Series C Preferred Stock, par value $0.01 per share (" Series C Preferred Stock "), for each outstanding share of the Company's common stock, par value $0.01 per share (" Common Stock ") to stockholders of record at 5:00 p.m. Eastern Time on May 20, 2024 (the " Record Date "). General; Transferability . Shares of Series C Preferred Stock will be uncertificated and represented in book-entry form. No shares of Series C Preferred Stock may be transferred by the holder thereof except in connection with a transfer by such holder of any shares of Common Stock held by such holder, in which case a number of one one-thousandths (1/1,000ths) of a share of Series C Preferred Stock equal to the number of shares of Common Stock to be transferred by such holder will be automatically transferred to the transferee of such shares of Common Stock. Voting Rights . Each share of Series C Preferred Stock will entitle the holder thereof to 1,000,000 votes per share (and, for the avoidance of doubt, each fraction of a share of Series C Preferred Stock will have a ratable number of votes). Thus, each one-thousandth (1/1,000th) of a share of Series C Preferred Stock would entitle the holder thereof to 1,000 votes. The outstanding shares of Series C Preferred Stock will vote together with the outstanding shares of Common Stock of the Company as a single class exclusively with respect to (1) any proposal to adopt an amendment to the Company's Sixth Amended and Restated Certificate of Incorporation, as amended (the " Certificate of Incorporation "), to increase the number of authorized shares of Common Stock in accordance with the terms of such amendment (the " Share Increase Proposal "), (2) any proposal to adopt an amendment to the Certifi
01. Financial
Item 9.01. Financial (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Document 3.1 Certificate of Designation of Preferences, Rights and Limitations. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ocugen, Inc. Date: May 10, 2024 By: /s/ Shankar Musunuri Name: Shankar Musunuri Title: Chairman, Chief Executive Officer, & Co-Founder